Inspiration Healthcare Group PLC Winning of Queen's Award for Enterprise

TIDMIHC

Inspiration Healthcare Group PLC

23 April 2019

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Wins Queen's Award for Enterprise

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, is delighted to announce that Inspiration Healthcare Ltd, a wholly owned subsidiary of the Company, has won the Queen's Award for Enterprise in recognition of the Company's outstanding level of International trade.

The Queen's Awards for Enterprise are the UK's most prestigious business awards. The International Trade category recognises outstanding growth in overseas earnings and year on year growth in overseas sales over a six-year period. Each year thousands of UK businesses enter this prestigious award programme.

Inspiration Healthcare Ltd exports its medical technology products for use in critical care and operating theatres to over 50 countries globally and has a network of over 80 active international distributors throughout the world. In its last annual financial report published in April 2018, international revenues rose by over 13% from the previous year to approximately GBP5milion, out of the Company's total revenue of GBP15.5million. Of this international revenue, approximately 62% originated from mainland Europe, 15% from the Middle East and Africa, approximately 13% from the USA and 10% from the rest of the world. The key products that Inspiration Healthcare exports are Tecotherm Neo, Inspire nCPAP and AlphaCore(5) .

Commenting, Neil Campbell, CEO said

"We are absolutely thrilled to have won the Queen's Award for Enterprise which recognises the hard work our team have put into developing our brand awareness as well as our business outside of the UK. It has taken many years to establish this international presence and we are justifiably proud of the recognition through gaining the most prestigious of UK business awards. Looking forward, we are confident that we will continue to grow our international business by developing and launching new medical products which are specifically designed to improve patient outcomes around the world."

Enquiries:

 
 Inspiration Healthcare Group      Tel: [phone] 
  plc 
  Neil Campbell, Chief Executive 
  Officer 
  Mike Briant, Chief Financial 
  Officer 
 Nominated Adviser & Broker        Tel: [phone] 
  Cenkos Securities plc 
  Mark Connelly 
  Cameron MacRitchie 
                                  ------------------- 
 Cadogan PR                        Tel: [phone] 
  Alex Walters 
                                  ------------------- 
 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NRADMGZDVZFGLZM

(END) Dow Jones Newswires

April 23, 2019 02:01 ET (06:01 GMT)